Pivotal Phase 2b clinical trial (ELPIS II) evaluating Lomecel-Bâ„¢ (laromestrocel) in Hypoplastic Left Heart Syndrome (HLHS), a rare pediatric ...
We remain committed to bringing an ophthalmic bevacizumab to market in the United States and providing retina patients suffering from wet AMD with a much needed treatment option that has the potential ...
Fapon Biopharma, a biotech innovator in developing therapeutic antibodies and fusion proteins, is pleased to announce that the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results